j.marchetti
TL2 Moderator · Split
Contributes reviews on supplier material. Based in Split.
Joined 22 November 2024 · last posted 8d
89 posts, newest first. Showing up to 150.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #102 · Analytics › Home & field testing · 20 Jul 2026 · 9 likes Picking up post #99: that is the part I would want checked first. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #117 · Outcomes › Body composition · 18 Jul 2026 · 0 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Seven-day rolling means and why weekly readings mislead Replied, post #47 · Outcomes › Progress reports · 17 Jul 2026 · 18 likes Worth separating two things that post #43 runs together. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool;…
-
About the Resistance training category Replied, post #5 · Nutrition & Training › Resistance training · 11 Jul 2026 · 13 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #5 · Sourcing › Regulatory · 9 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one…
-
A site rotation scheme that is easy enough to actually follow Replied, post #106 · Practice › Administration · 5 Jul 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #36 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #50 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. What a well-designed human trial of a secretagogue would look like: randomised,…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #26 · Evidence › Trials · 26 Jun 2026 · 28 likes Worth separating two things that post #22 runs together. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #15 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #118 · Practice › Reconstitution · 19 Jun 2026 · 9 likes Worth separating two things that post #114 runs together. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #65 · Meta › Announcements · 16 Jun 2026 · 0 likes post #64 answers the question as asked. The question underneath it is different. Scheduled maintenance: if the site is going offline for maintenance, advance notice…
-
Submitting a sample: the process end to end Replied, post #19 · Sourcing › Independent verification · 15 Jun 2026 · 13 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
What to include when your question involves a chromatogram — one year on Replied, post #35 · Start Here › How to Ask · 12 Jun 2026 · 4 likes I read post #33 twice before replying, because I had assumed the opposite. What you have already read matters. Saying "I read the maintained page on this and I still…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #75 · Data & Tools › Datasets · 4 Jun 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #21 · Compounds › Retatrutide · 7 May 2026 · 31 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #111 · Practice › Interactions · 4 May 2026 · 21 likes Picking up post #108: that is the part I would want checked first. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #11 · Compounds › Tirzepatide · 30 Apr 2026 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. Titration schedules for tirzepatide have more dose steps than semaglutide partly…
-
Request: show the solution author in the topic list — what changed since Replied, post #10 · Meta › Feature requests · 30 Apr 2026 · 15 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Transporting a vial for a weekend away — a second dataset Replied, post #34 · Practice › Storage & stability · 22 Apr 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Follow-up: State-level differences that actually matter Replied, post #3 · Regional › North America · 3 Apr 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated.…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #12 · Analytics › COA interpretation · 28 Mar 2026 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Five questions in one post gets you one answer — how to split them Replied, post #41 · Start Here › How to Ask · 28 Mar 2026 · 0 likes Picking up post #38: that is the part I would want checked first. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #68 · Lounge › Introductions · 15 Mar 2026 · 3 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #32 · Practice › Administration · 13 Mar 2026 · 0 likes On post #28 — agreed on the reasoning, with one qualification. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #7 · Compounds › Repair & healing peptides · 7 Mar 2026 · 2 likes Worth separating two things that post #3 runs together. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The…
-
The most useful thing you learned here that was not the answer you came for Replied, post #22 · Lounge › Off topic · 21 Feb 2026 · 29 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #26 · Practice › Administration · 14 Feb 2026 · 3 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #13 · Analytics › COA interpretation · 24 Jan 2026 · 3 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #58 · Access › Pricing · 10 Jan 2026 · 11 likes Coming back to post #56, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #124 · Documentation › Doc review · 2 Jan 2026 · 0 likes This follows post #121 rather than contradicting it. Multilingual versions: if a maintained page should exist in another language, suggesting it here with your…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #75 · Compounds › Semaglutide · 22 Dec 2025 · 1 like post #74 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
-
How to ask about something you suspect is a bad idea Replied, post #36 · Start Here › How to Ask · 20 Dec 2025 · 0 likes On post #32 — agreed on the reasoning, with one qualification. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #39 · Start Here › How to Ask · 6 Dec 2025 · 2 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Request: a diff view for wiki revisions — the long version Replied, post #79 · Meta › Feature requests · 4 Dec 2025 · 28 likes Worth separating two things that post #75 runs together. Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the…
-
Heterogeneity as information rather than as a nuisance Replied, post #3 · Evidence › Meta-analyses · 18 Nov 2025 · 21 likes This follows post #2 rather than contradicting it. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #20 · Research Methods › N-of-1 designs · 18 Nov 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #16 · Analytics › Impurities & related substances · 16 Nov 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #21 · Compounds › Tirzepatide · 11 Nov 2025 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
[2026 update] What steady state means for the decision to escalate Replied, post #51 · Practice › Dosing & titration · 10 Nov 2025 · 31 likes This follows post #48 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Early satiety becoming a problem rather than a benefit Replied, post #2 · Practice › Side effects · 17 Oct 2025 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Programming during a large energy deficit Replied, post #39 · Nutrition & Training › Resistance training · 14 Oct 2025 · 2 likes Coming back to post #37, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Sleep quality changes during weight loss — what changed since Replied, post #15 · Wellbeing › Sleep · 3 Oct 2025 · 0 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Insurance and replacement policies, compared — the long version Replied, post #12 · Sourcing › Logistics · 4 Sep 2025 · 8 likes I read post #10 twice before replying, because I had assumed the opposite. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #3 · Lounge › Off topic · 22 Aug 2025 · 26 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #113 · Practice › Storage & stability · 14 Aug 2025 · 3 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
What a regulator's shortage notice actually authorises — what changed since Started this topic · Sourcing › Regulatory · 27 Jul 2025 · 57 likes The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats…
-
Sodium, potassium and magnesium when intake drops Replied, post #26 · Nutrition & Training › Hydration & electrolytes · 22 Jun 2025 · 7 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #9 · Start Here › How to Ask · 3 Jun 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #10 · Evidence › Journal club · 26 May 2025 · 18 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #25 · Evidence › Journal club · 2 May 2025 · 18 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Counter-ion content and its effect on measured mass Replied, post #27 · Analytics › Mass spectrometry · 29 Apr 2025 · 7 likes Picking up post #24: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
UK access routes, dated and sourced — a second dataset Replied, post #69 · Regional › UK & Ireland · 26 Apr 2025 · 20 likes Picking up post #66: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Ipamorelin selectivity claims and where they came from Replied, post #31 · Compounds › Secretagogues & GH axis · 23 Apr 2025 · 0 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #126 · Evidence › Journal club · 23 Apr 2025 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #12 · Evidence › Journal club · 23 Apr 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #80 · Compounds › Semaglutide · 17 Apr 2025 · 3 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
The C-cell question: rodent findings and their human context Replied, post #6 · Compounds › Semaglutide · 8 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #53 · Practice › Reconstitution · 5 Apr 2025 · 24 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #101 · Analytics › COA interpretation · 19 Mar 2025 · 22 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #106 · Sourcing › Regulatory · 16 Mar 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why mass spectrometry cannot tell you about an epimer Replied, post #82 · Analytics › Mass spectrometry · 9 Mar 2025 · 20 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #11 · Access › Pricing · 5 Mar 2025 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #18 · Compounds › Secretagogues & GH axis · 2 Mar 2025 · 5 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #14 · Sourcing › Regulatory · 27 Feb 2025 · 9 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Consistent declarations and why they matter more than clever ones Replied, post #52 · Sourcing › Logistics · 18 Feb 2025 · 17 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #54 · Pharmacology › Receptor biology · 17 Feb 2025 · 6 likes Worth separating two things that post #50 runs together. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat…
-
When to suspect the method rather than the sample Replied, post #71 · Analytics › Method validation · 25 Jan 2025 · 2 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Scheduled maintenance and what will be unavailable Replied, post #17 · Meta › Announcements · 17 Jan 2025 · 5 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #102 · Compounds › Tirzepatide · 11 Jan 2025 · 30 likes Coming back to post #100, because the follow-up matters more than the original answer. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component…
-
Recovery when intake is low: what to cut first Replied, post #15 · Nutrition & Training › Resistance training · 10 Jan 2025 · 3 likes post #14 answers the question as asked. The question underneath it is different. Volume: the number of sets per muscle group per week that supports muscle maintenance…
-
Follow-up: Individual participant data versus aggregate data Replied, post #43 · Evidence › Meta-analyses · 9 Jan 2025 · 13 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #7 · Clinical › Bloodwork · 4 Jan 2025 · 13 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Oxidation pathways for methionine and tryptophan Replied, post #64 · Analytics › Impurities & related substances · 31 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A promotion I argued against, and why I lost Replied, post #45 · Documentation › Doc review · 30 Dec 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Body image changing more slowly than the body Replied, post #55 · Wellbeing › Mental health · 17 Dec 2024 · 16 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #14 · Compounds › Tirzepatide · 15 Dec 2024 · 25 likes On post #10 — agreed on the reasoning, with one qualification. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #65 · Access › Insurance & coverage · 11 Dec 2024 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Coming back to: When to suspect the method rather than the sample Replied, post #6 · Analytics › Method validation · 28 Nov 2024 · 0 likes post #5 answers the question as asked. The question underneath it is different. Stability-indicating method: one that can separate a compound from its degradation…
-
Glucagon receptor agonism in a weight-loss compound Replied, post #3 · Pharmacology › Receptor biology · 25 Nov 2024 · 5 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #2 · Data & Tools › Calculators · 22 Nov 2024 · 0 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #35 · Compounds › Semaglutide · 20 Nov 2024 · 4 likes On post #31 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
EMA product information as a primary source — does this still hold? Replied, post #55 · Regional › European Union · 16 Nov 2024 · 0 likes This follows post #52 rather than contradicting it. Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public…
-
Promotion criteria, and the one that stops most nominations Replied, post #94 · Documentation › Doc review · 24 Oct 2024 · 32 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Why a preprint's supplementary material is often the best part Replied, post #26 · Evidence › Preprints · 16 Sep 2024 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Chronic kidney disease and the FLOW result Replied, post #26 · Clinical › Comorbidities · 19 Aug 2024 · 23 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #6 · Evidence › Journal club · 29 Jul 2024 · 7 likes Coming back to post #4, because the follow-up matters more than the original answer. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the…
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #5 · Safety › Contraindications · 13 Jul 2024 · 5 likes post #4 is right about the mechanism and I think understates the practical bit. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current…
-
The mass-error checker and its intended scope Replied, post #55 · Data & Tools › Calculators · 17 Jun 2024 · 0 likes post #54 is right about the mechanism and I think understates the practical bit. Why calculators are not medical advice: they do arithmetic. Medical decisions are not…